Company: VRCA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0000950170-25-107358
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 no shares issued and outstanding as of June 30, 2025 and December 31, 2024

     —

     —

     Common stock, $0.0001 par value; 200,000,000 authorized; 9,265,034 shares issued and 9,254,520 shares outstanding as of June 30, 2025 and 9,188,513 shares issued and 9,177,999 shares outstanding as of December 31, 2024

     1

     1

     Treasury stock, at cost, 10,514 shares as of June 30, 2025 and December 31, 2024

     —

     —

     Additional paid-in capital

     299,080

     297,166

     Accumulated deficit

     (316,565
     )

     (307,027
     )

     Total stockholders’ deficit

     (17,484
     )

     (9,860
     )

     Total liabilities and stockholders’ deficit
      
     $
     39,107

     $
     54,134

The accompanying notes are an integral part of these financial statements.